compname posts q3 adjusted earnings per share $1.97.
q3 adjusted earnings per share $1.97 .
sees fy adjusted earnings per share $7.90 to $8.00.
qtrly total revenues increased to $73.8 billion, up 10.0% compared to prior year.
raised 2021 cash flow from operations guidance range to $13.0 billion to $13.5 billion from $12.5 billion to $13.0 billion.
qtrly adjusted operating income increased 12.5% primarily due to administration of covid-19 vaccinations and diagnostic testing.
administered more than 8 million covid-19 tests and more than 11 million covid-19 vaccines nationwide in q3.
